Licensed Practical Nurse in Carlisle, OH Accepting Medicare
5 Licensed Practical Nurse nurses found. Showing 1 - 5
 Mr. Anthony Scott Hawkins, L.P.N. Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 8713 Windsong Ct, Carlisle, OH 45005 Phone: 513-217-5089 |
 Miss Tanya Ann Sutter, L.P.N Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 101 Arthur Ave, Carlisle, OH 45005 Phone: 937-550-4053 |
Amanda R Salyer, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1101 Dubois Rd, Carlisle, OH 45005 Phone: 513-594-6462 |
Ms. Heather Lynn Pesante Bass, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 8736 Franklin Trenton Rd, Carlisle, OH 45005 Phone: 513-292-4378 |
Mr. Robert Dale Spencer Jr., LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 7164 Country Walk Dr, Carlisle, OH 45005 Phone: 937-673-7651 |
News Archive
GlobalData reveals 21.7% drop in US medical devices industry deals during April 2020
The US medical devices industry saw a drop of 21.7% in overall deal activity during April 2020, when compared with the last 12-month average, according to GlobalData's deals database.
Neurexin proteins play key role in formation of synaptic connections
Neuroscientists and bioengineers at Stanford are working together to solve a mystery: how does nature construct the different types of synapses that connect neurons - the brain cells that monitor nerve impulses, control muscles and form thoughts.
Genetic modification of common virus gives extra weapon to kill cancer cells
A common flu virus could be used to overcome patients' resistance to certain cancer drugs - and improve how those drugs kill cancer cells, according to new research from Queen Mary University of London.
FDA accepts Ampio's Patient Outcome for Premature Ejaculation questionnaire
Ampio Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat prevalent inflammatory diseases, such as osteoarthritis (Ampion) and diabetic macular edema (Optina) and sexual dysfunction (Zertane) announced FDA acceptance of its POPE questionnaire, a modification of the Premature Ejaculation Profile (PEP) questionnaire that was used in the two successful Zertane Phase 3 clinical trials completed in Europe.
› Verified 8 days ago